- Home
- JVA vs TENX Comparison
JVA vs TENX Comparison
Compare JVA & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JVA
- TENX
- Stock Information
- Founded
- JVA 1971
- TENX 1967
- Country
- JVA United States
- TENX United States
- Employees
- JVA N/A
- TENX N/A
- Industry
- JVA Packaged Foods
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- JVA Consumer Staples
- TENX Health Care
- Exchange
- JVA Nasdaq
- TENX Nasdaq
- Market Cap
- JVA 23.8M
- TENX 25.8M
- IPO Year
- JVA 2005
- TENX N/A
- Fundamental
- Price
- JVA $4.21
- TENX $5.85
- Analyst Decision
- JVA
- TENX Strong Buy
- Analyst Count
- JVA 0
- TENX 3
- Target Price
- JVA N/A
- TENX $16.00
- AVG Volume (30 Days)
- JVA 75.5K
- TENX 23.2K
- Earning Date
- JVA 09-12-2025
- TENX 08-19-2025
- Dividend Yield
- JVA N/A
- TENX N/A
- EPS Growth
- JVA 856.08
- TENX N/A
- EPS
- JVA 0.65
- TENX N/A
- Revenue
- JVA $84,651,329.00
- TENX N/A
- Revenue This Year
- JVA N/A
- TENX N/A
- Revenue Next Year
- JVA N/A
- TENX N/A
- P/E Ratio
- JVA $6.49
- TENX N/A
- Revenue Growth
- JVA 15.86
- TENX N/A
- 52 Week Low
- JVA $1.86
- TENX $3.25
- 52 Week High
- JVA $9.93
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- JVA 46.60
- TENX 40.47
- Support Level
- JVA $4.31
- TENX $5.80
- Resistance Level
- JVA $4.33
- TENX $6.25
- Average True Range (ATR)
- JVA 0.22
- TENX 0.24
- MACD
- JVA -0.04
- TENX -0.04
- Stochastic Oscillator
- JVA 33.33
- TENX 10.31
About JVA Coffee Holding Co. Inc.
Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.